Tag: overweight

Latest News

Website errors raise calls for Medicare to Be flexible with seniors’ enrollment

Newsemia
Beneficiaries are going to be able to change plans next year because of misinformation through the website for Medicare enrollment although officials provided few details....
AI/ML

Does whole body vibration therapy assist in reducing fat mass or treating obesity in healthy overweight and obese adults? A systematic review and meta-analyses.

Newsemia
Related Articles Does whole body vibration therapy assist in reducing fat mass or treating obesity in healthy overweight and obese adults? A systematic review and...
Latest News

What will it take to improve recruitment for clinical trials?

Newsemia
Whether clinical trial travel requires a short rideshare trip or a flight halfway across the world, the key to keeping participants enrolled and engaged is...
Latest News

Angion’s kidney therapy advances

Newsemia
The 28-patient study showed that Angion’s drug improved kidney function, based on patients’ estimated glomerular filtration rate (eGFR), a key renal function metric. Source link...
Latest News

Why Google is buying Fitbit

Newsemia
We spoke to investors and analysts to figure out why Google is buying Fitbit, a company that hasn’t made much of a dent in the...
Latest News

Amgen to stop selling Repatha at higher list price, offer low-priced option exclusively

Newsemia
The biotech company had kept the drug available at the higher list price in order to give payers and pharmacy benefit managers time to adjust...
Latest News

Download the HLTH app to maximize your networking game

Newsemia
In its second year, HLTH is offering a smorgasbord of programs designed to facilitate networking at its conference at the MGM Grand in Las Vegas October...
Latest News

Get ready for the second annual HLTH conference

Newsemia
MedCity’s patient engagement conference ENGAGE will be part of the HLTH conference for the first time this year. ENGAGE at HLTH on October 28 will feature innovators from...
Latest News

UCB psoriasis drug beats J&J’s second top-selling product in Phase III study

Newsemia
Results of the BE VIVID study showed that UCB’s bimekizumab showed a statistically significant improvement in skin clearance compared with J&J’s Stelara and placebo. Source...
Latest News

Whistleblower alleges Medicare fraud at iconic Seattle-based health plan

Newsemia
The Justice Department has thus far declined to take over the case, which alleges wrongdoing by Seattle-based nonprofit health plan, Group Health, but said in...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy